Status:
NOT_YET_RECRUITING
Flaxseed Consumption on Biochemical and Quality of Life in Type 2 Diabetes
Lead Sponsor:
Ondokuz Mayıs University
Conditions:
Type 2 Diabetes Mellitus (T2DM)
Eligibility:
All Genders
19-65 years
Phase:
NA
Brief Summary
The main goal of this clinical trial is to determine the effect of flaxseed added to the diet on biochemical parameters and quality of life in patients with Type 2 diabetes mellitus (T2DM). The main q...
Detailed Description
Adult individuals between the ages of 19-65, with a body mass index (BMI) between 20-35 kg/m2, using oral anti-diabetics and not using insulin will be included in the study. Patients with T2DM who agr...
Eligibility Criteria
Inclusion
- Diagnosed with T2DM by a physician
- Being between the ages of 19-65
- Having a body mass index (BMI) between 20-35 kg/m2
- Using oral anti-diabetics and not using insulin
Exclusion
- History of gastrointestinal diseases
- High consumption of nuts, flaxseeds or sesame seeds (more than one serving per day)
- Food allergies or intolerances
- Malignancies
- Renal failure, liver, other endocrine or inflammatory disorders
- Use of lipid-lowering drugs
- Smoking and alcohol use
- Being pregnant or lactating
Key Trial Info
Start Date :
September 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 12 2026
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT06911060
Start Date
September 1 2025
End Date
May 12 2026
Last Update
August 12 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.